- ￥640 - 800
- Sino Biological
- STF02
- 北京
- 2025年08月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 保存条件：
低温
- 保质期：
12个月
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 英文名：
Sinofection Transfection Reagent
- 规格：
0.75 mL/1 mL
| 规格： | 0.75 mL | 产品价格： | ￥640 |
|---|---|---|---|
| 规格： | 1 mL | 产品价格： | ￥800 |
Sinofection® 高效转染试剂
Sinofection® 是优良的阳离子聚合物转染试剂。与其他脂质体转染试剂相比，Sinofection® 产品细胞毒性低、转染效率高以及重复性高。
Sinofection® 转染试剂产品优势
| • 操作简单，转染瞬时，效率高 | • 用量少，性价比高 |
| • 无机试剂，无动物源成分 | • 蛋白表达量高，细胞毒性低 |
| • 产品质量稳定，质控严格 | • 细胞通用性好，适用于 HEK293 等真核细胞培养 |
| • 适用于贴壁细胞和悬浮acc细胞的转染 | • 适用于有血清和无血清的转染条件 |
| • 具有 200,000L 以上的工业化生产应用 |
Sinofection® 转染试剂产品信息
| 货号 | 名称 | 类型 | 应用 |
| STF02 | Sinofection 转染试剂 | 阳离子聚合物 | DNA转染，适用于 HEK293 以及其他类型细胞的转染 |
Sinofection® 转染试剂适用的细胞类型：
| • HEK293H | • MCF7 | • Hela | • A549 |
| • HEK293FT | • SW480 | • Caco2 | • NIH/3T3 |
| • HEK293E | • MDCK | • BHK21 | • Vero |
| • HEK293F | • CHO-K1 | • CHO-DG44 | • SF9 |
| • COS7 | • HepG2 | • RAW264.7 |
Sinofection® 转染案例
| 293E | 293FT | ||
| COS7 | HepG2 | ||
| BHK21 | MCF7 | ||
| SW480 | CHO-DG44 | ||
Sinofection® 转染试剂的详细使用说明，您可下载下方产品说明书查看。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验该产品被引用文献
1, Chen, P; et al. Pharmacological characterization of the 5-HT1A receptor of Bombyx mori and its role in locomotion. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol., Pubmed: 30690153
2, Hu, Y; et al. Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs. The EMBO journal, Pubmed: 36519268
3, Liang, X; et al. Therapeutic inhibition of SGK1 suppresses colorectal cancer. Exp. Mol. Med., Pubmed: 29170478
4, Wang, Z; et al. Premature Stop Codon at Residue 101 within HIV-1 Rev Does Not Influence Viral Replication of Clade BC but Severely Reduces Viral Fitness of Clade B. Virol Sin, Pubmed: 31828587
5, Zha, L; et al. Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles. bioRxiv
6, Xie, L; et al. SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development. bioRxiv
7, Dai, M; et al. Systematic identification of chicken type I, II and III interferon-stimulated genes. Vet. Res., Pubmed: 32448397
8, Zhang, L; Yao, HR; Liu, SK. Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer. European Review for Medical and Pharmacological Sciences
2, Hu, Y; et al. Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs. The EMBO journal, Pubmed: 36519268
3, Liang, X; et al. Therapeutic inhibition of SGK1 suppresses colorectal cancer. Exp. Mol. Med., Pubmed: 29170478
4, Wang, Z; et al. Premature Stop Codon at Residue 101 within HIV-1 Rev Does Not Influence Viral Replication of Clade BC but Severely Reduces Viral Fitness of Clade B. Virol Sin, Pubmed: 31828587
5, Zha, L; et al. Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles. bioRxiv
6, Xie, L; et al. SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development. bioRxiv
7, Dai, M; et al. Systematic identification of chicken type I, II and III interferon-stimulated genes. Vet. Res., Pubmed: 32448397
8, Zhang, L; Yao, HR; Liu, SK. Long noncoding RNA ROR1‑AS1 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in cervical cancer. European Review for Medical and Pharmacological Sciences
文献支持
高效转染试剂 Sinofection®
￥640 - 800
